Olimel 5.7% E 3.67 g (Sodium Glycerophosphate EMULSION) 3.67 G

Olime 5.7% E 3.67 G is a sodium glycerophosphate emulsion used for intravenous administration. This pharmaceutical product supports electrolyte balance and is available in various pack sizes for medical use.

Strength

3.67 G

Pack Size

1000/1500/2000/2500ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Olime 5.7% E 3.67 G is primarily used to provide sodium and phosphate, which are essential for maintaining electrolyte balance in the body. This intravenous emulsion is often utilized in clinical settings where oral intake is not feasible or sufficient. It is important to consult healthcare professionals to determine the appropriate use of this product.

Side Effects

The administration of Olime 5.7% E 3.67 G may help in maintaining normal electrolyte levels, which are crucial for various bodily functions. Users may experience improved hydration and electrolyte balance when this product is used as directed by a healthcare provider.

Precautions & Warnings

Olime 5.7% E 3.67 G should be handled with care and administered under the supervision of a healthcare professional. It is important to follow proper storage guidelines to maintain the integrity of the emulsion. Always check the packaging for any specific instructions or warnings.

Avoid Interactions

Olime 5.7% E 3.67 G may interact with other medications or supplements, particularly those affecting electrolyte balance. It is advisable to inform healthcare providers about all current medications before using this product to avoid potential interactions.

Frequently Asked Questions

Olime 5.7% E 3.67 G is used to provide sodium and phosphate intravenously, supporting electrolyte balance in the body.

Olime 5.7% E 3.67 G is administered intravenously and should be done under the supervision of a healthcare professional.

The common effects include maintaining normal electrolyte levels and improving hydration when used as directed.

Yes, it should be handled with care, administered under supervision, and stored properly to maintain its integrity.

Yes, it may interact with other medications affecting electrolyte balance, so it's important to consult a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.